Encapsulation of therapeutic molecules into nanocarrier is an extensively explored strategy to treat cancer more effectively. In this study, pH-responsive targeting dual-agent delivery nanoparticles were prepared, into which hydrophilic doxorubicin hydrochloride (DOX) and hydrophobic curcumin (CUR) were entrapped. Tyrosine (Tyr) was grafted onto poly(aspartic acid) (PASP) to produce PASP-Tyr, the following reaction between hyaluronic acid (HA) and ethylenediamine (EDA) modified PASP-Tyr formed the nanocarrier HA-EDA-PASP-Tyr (HEPT), and the loading capacity was up to 50.9 ± 4.3% for CUR and 26.0 ± 1.9% for DOX. The spherical HEPT with the mean particle size of 142.9 ± 11.4 nm expanded and deformed into petaloid pattern with an increased size of about 2 µm when triggered by the acidic microenvironment. In vitro anticancer activity evaluation revealed that the co-loaded (DOX+CUR)@HEPT nanoparticles presented higher cytotoxicity against HCT-116 cells compared with that of the free combination of (DOX+CUR). Confocal laser scanning microscopy observation indicated that HEPT carrier promoted cellular uptake of drugs by means of active targeting capacity of HA ligand. With high loading capacity and tailored carrier structure, the nanoparticles formulations may offer a new strategy for cancer treatment.
SunTZhangYSPangB, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl2014; 53: 12320–12364.
2.
WenSHLiuHCaiHD, et al. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Adv Healthc Mater2013; 2: 1267–1276.
3.
LiCWangJCWangYG, et al. Recent progress in drug delivery. Acta Pharm Sin B2019; 9: 1145–1162.
4.
HossenSHossainMKBasherMK, et al. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res2019; 15: 1–18.
5.
NorouziMAmerianMAmerianM, et al. Clinical applications of nanomedicine in cancer therapy. Drug Discov Today2020; 25: 107–125.
6.
NabilGBhiseKSauS, et al. Nano-engineered delivery systems for cancer imaging and therapy: recent advances, future direction and patent evaluation. Drug Discov Today2019; 24: 462–491.
7.
LiuMMWangLLSuHJ, et al. pH-sensitive IPN hydrogel based on poly (aspartic acid) and poly (vinyl alcohol) for controlled release. Polym Bull2013; 70: 2815–2827.
8.
LiWMSuCWChenYW, et al. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs. Acta Biomater2015; 15: 191–199.
9.
ZhangYCaiLLLiD, et al. Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res2018; 11: 4806–4822.
10.
CagelMGrotzEBernabeuE, et al. Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov Today2017; 22: 270–281.
11.
Granados-PrincipalSEl-AzemNPamplonaR, et al. Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer. Biochem Pharmacol2014; 90: 25–33.
12.
LiuHSKeCSChengHC, et al. Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of Aurora A. Mol Pharmacol2011; 80: 638–646.
13.
SinghMSinghN.Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol Cell Biochem2011; 347: 1–11.
14.
LachowiczDKarabaszABzowskaM, et al. Blood-compatible, stable micelles of sodium alginate – curcumin bioconjugate for anti-cancer applications. Eur Polym J2019; 113: 208–219.
15.
DattaRHalderSKZhangBH.Role of TGF-beta signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. J Cancer Res Clin Oncol2013; 139: 563–572.
16.
SabziARahmaniAEdalatiM, et al. Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized poly (epsilon-caprolactone) based micelle in MDA-MB-231 cell. Colloid Surf B-Biointerfaces2020; 194
17.
TesauroDAccardoADiaferiaC, et al. Peptide-based drug-delivery systems in biotechnological applications: recent advances and perspectives. Molecules2019; 24: 351.
18.
TiwariSBahadurP.Modified hyaluronic acid based materials for biomedical applications. Int J Biol Macromol2019; 121: 556–571.
19.
ChoiHJeenaMTPalanikumarL, et al. The HA-incorporated nanostructure of a peptide-drug amphiphile for targeted anticancer drug delivery. Chem Commun (Camb)2016; 52: 5637–5640.
20.
BhattacharyaDSSvechkarevDBapatA, et al. Sulfation modulates the targeting properties of hyaluronic acid to P-Selectin and CD44. ACS Biomater Sci Eng2020; 6: 3585–3598.
21.
YangHYLiYJangMS, et al. Green preparation of pH-responsive and dual targeting hyaluronic acid nanogels for efficient protein delivery. Eur Polym J2019; 121: 109342.
22.
ZhengPLiuYChenJJ, et al. Targeted pH-responsive polyion complex micelle for controlled intracellular drug delivery. Chin Chem Lett2020; 31: 1178–1182.
23.
RuttalaHBChitrapriyaNKalirajK, et al. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy. Acta Biomater2017; 63: 135–149.
24.
LiaoJHSongYJLiuC, et al. Dual-drug delivery based charge-conversional polymeric micelles for enhanced cellular uptake and combination therapy. Polym Chem2019; 10: 5879–5893.
25.
TorchilinVP.Structure and design of polymeric surfactant-based drug delivery systems. J Control Release2001; 73: 137–172.
26.
LiSPZhaoWLiangN, et al. Multifunctional micelles self-assembled from hyaluronic acid conjugate for enhancing anti-tumor effect of paclitaxel. React Funct Polym2020; 152: 104608.
27.
JangL-SKengH-K.Modified fabrication process of protein chips using a short-chain self-assembled monolayer. Biomed Microdevices2008; 10: 203–211.
28.
YokoyamaMFukushimaSUeharaR, et al. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release1998; 50: 79–92.
29.
LiWMChiangCSHuangWC, et al. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer. J Control Release2015; 220: 107–118.
30.
MaWZGuoQLiY, et al. Co-assembly of doxorubicin and curcumin targeted micelles for synergistic delivery and improving anti-tumor efficacy. Eur J Pharm Biopharm2017; 112: 209–223.
